Bristol-Myers Squibb launched TAXOL (paclitaxel)
In 1993, Bristol-Myers Squibb launched TAXOL (paclitaxel). The company invested hundreds of millions of dollars to supply TAXOL…
Biotechnology | Disease | FDA | Oncology | Therapeutics
Taxol (paclitaxel) approved by the FDA for the treatment of ovarian cancer that has failed other therapy
On Dec. 18, 1992, Taxol (paclitaxel), an anticancer drug extracted from the bark of the Pacific yew, received…
Biotechnology | Diagnostics | Disease | Forestry | Non-Profit Research | Oncology | Therapeutics | Women's Health
Albert Einstein Cancer Center researchers identified the mechanism of action of Taxol
In 1976, Albert Einstein Cancer Center researchers identified the mechanism of action of Taxol, one of the most…